Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9- yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells

Amareshwar T.K. Singh*, Julie M. Radeff, Joseph G. Kunnel, Paula H. Stern

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9- yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences